| Lindsay Helene Morrell, MD | |
|
6565 N Charles St, Suite 212, Towson, MD 21204-6800 | |
| (410) 823-1120 | |
| Not Available |
| Full Name | Lindsay Helene Morrell |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 12 Years |
| Location | 6565 N Charles St, Towson, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942561519 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D0080917 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Womens Care Llc | 4880582741 | 248 |
News Archive
Svelte Medical Systems today announced treatment of the first patient in the DIRECT (Direct-on-a-wire Implantation of Rapamycin-eluting stent with bio-Eroding Carrier Technology) study at Auckland City Hospital in Auckland, New Zealand.
Schizophrenia causes hallucinations and memory or cognition problems inter alia. This psychiatric illness affects 0.5% of the general population, and it may be related to genetic abnormalities of chromosome 22, known as 22q11 deletion syndrome.
Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.
Pediatric brain tumors are characterized by frequent complications due to intractable epilepsy compared to adult brain tumors. However, the genetic cause of refractory epilepsy in pediatric brain tumors has not been elucidated yet, and it is difficult to treat patients because the tumors do not respond to existing antiepileptic drugs and debilitate children's development.
› Verified 5 days ago
| Entity Name | Capital Womens Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679534069 PECOS PAC ID: 4880582741 Enrollment ID: O20050804000705 |
News Archive
Svelte Medical Systems today announced treatment of the first patient in the DIRECT (Direct-on-a-wire Implantation of Rapamycin-eluting stent with bio-Eroding Carrier Technology) study at Auckland City Hospital in Auckland, New Zealand.
Schizophrenia causes hallucinations and memory or cognition problems inter alia. This psychiatric illness affects 0.5% of the general population, and it may be related to genetic abnormalities of chromosome 22, known as 22q11 deletion syndrome.
Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.
Pediatric brain tumors are characterized by frequent complications due to intractable epilepsy compared to adult brain tumors. However, the genetic cause of refractory epilepsy in pediatric brain tumors has not been elucidated yet, and it is difficult to treat patients because the tumors do not respond to existing antiepileptic drugs and debilitate children's development.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsay Helene Morrell, MD 8110 Maple Lawn Blvd Ste 235, Fulton, MD 20759-2694 Ph: (301) 340-8339 | Lindsay Helene Morrell, MD 6565 N Charles St, Suite 212, Towson, MD 21204-6800 Ph: (410) 823-1120 |
News Archive
Svelte Medical Systems today announced treatment of the first patient in the DIRECT (Direct-on-a-wire Implantation of Rapamycin-eluting stent with bio-Eroding Carrier Technology) study at Auckland City Hospital in Auckland, New Zealand.
Schizophrenia causes hallucinations and memory or cognition problems inter alia. This psychiatric illness affects 0.5% of the general population, and it may be related to genetic abnormalities of chromosome 22, known as 22q11 deletion syndrome.
Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.
Pediatric brain tumors are characterized by frequent complications due to intractable epilepsy compared to adult brain tumors. However, the genetic cause of refractory epilepsy in pediatric brain tumors has not been elucidated yet, and it is difficult to treat patients because the tumors do not respond to existing antiepileptic drugs and debilitate children's development.
› Verified 5 days ago
Thelma S Asare, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 West Rd, Suite 404, Towson, MD 21204 Phone: 410-832-5511 Fax: 410-832-5560 | |
Dr. Marwan Ahmad Hajj, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6569 N Charles Street, Suite 710, Towson, MD 21204 Phone: 410-321-1313 Fax: 410-321-1366 | |
Dr. Arthur William Nauman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 22 West Rd Ste 300, Towson, MD 21204 Phone: 410-321-6100 Fax: 443-275-2465 | |
Mary Anne Facciolo, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7801 York Rd, Ste 133, Towson, MD 21204 Phone: 410-339-7447 Fax: 410-339-3684 | |
Dr. Giles Harrison Manley, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6904 N Charles St, Towson, MD 21204 Phone: 410-916-6712 Fax: 410-653-3200 | |
Monica A Buescher, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7801 York Rd, Suite 133, Towson, MD 21204 Phone: 410-339-7447 Fax: 410-339-3684 | |
Dr. Andrea C Fitzgerald, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7401 Osler Dr, Suite 205, Towson, MD 21204 Phone: 410-828-8077 Fax: 410-828-8077 |